PARICALCITOL Capsules — Class III drug recall D-0109-2017
Terminated recall by Teva Pharmaceuticals USA, reported 2016-10-26, distributed nationwide. Failed Impurities/Degradation Specifications: out of specification test results for impurities during stabilit
| Recall number | D-0109-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2016-09-22 |
| Classified | 2016-10-19 |
| Reported by FDA | 2016-10-26 |
| Terminated | 2017-05-05 |
| Distributed | Nationwide (US) |
| Quantity | 32,015 bottles |
| Reason classes | specification failure |
| NDC | 00093-7656-56 |
| Lot numbers | 04/17, 13013.013A |
Product
PARICALCITOL Capsules, 1 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7656-56.
Reason for recall
Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0109-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.